Tradestie Institutional Equity Comparison Engine
ALMS vs MPLT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MPLT Overall Edge
MPLT Captures Institutional Edge (2โ1 Pillars ยท 5โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MapLight Therapeutics, Inc. (MPLT) driven by superior Growth & Margin, Momentum & Technical while ALMS counters with relative strength in Options & Structure. Fundamentally, ALMS trades at N/M Forward P/E with -5744.5% operating margin (-37.7% YoY revenue) versus MPLT at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ALMS sits in BREAKDOWN (8th %ile IV; Dealer Gamma Walls on Pro) against MPLT sits in BREAKDOWN (8th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
ALMS N/M vs MPLT N/M Fwd P/E
Growth & Margin Winner
MPLT
Op Margin -5744.5% vs 0.0% ยท YoY -37.7% vs +0.0%
Momentum & Technical Winner
MPLT
1Y -4.2% vs -51.4% ยท 52W Pos 2% vs 3%
Options & Structure Winner
ALMS
BREAKDOWN (8th %ile IV) vs BREAKDOWN (8th %ile IV)
ALMS
NASDAQ
Alumis Inc. Common Stock
Pharmaceutical Preparations
$5.06
-9.65% 1D
Market Cap
$793.4M
1M Return
-17.33%
1Y Return
-4.18%
Forward P/E
N/M
Unified AI Score
43.3 / 100
HOLD
Tech 20.0
Fund 51.0
Flow 67.0
Mom 74.0
MPLT
US Equity
MapLight Therapeutics, Inc.
Pharmaceutical Preparations
$6.94
-4.28% 1D
Market Cap
$392.9M
1M Return
-9.87%
1Y Return
-51.4%
Forward P/E
N/M
Unified AI Score
50.4 / 100
HOLD
Tech 49.0
Fund 56.0
Flow 64.0
Mom 58.9
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ALMS -4.18%
MPLT -51.4%
Spread: +47.22 pp (ALMS Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ALMS TTM Op. Margin: -5744.5%
MPLT TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ALMS vs MPLT. Trailing 12-month operating profitability (ALMS -5744.5% vs MPLT 0.0%) and valuation multiples (ALMS N/M vs MPLT N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ALMS | MPLT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $793.4M | $392.9M | Larger Scale | ALMS |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -37.7% | +0.0% | Higher Growth | MPLT |
| Operating Margin (TTM) Profitability | -5744.5% | 0.0% | Higher Margin | MPLT |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -93.7% | -111.5% | Higher ROE | ALMS |
| 52-Week Range Position Momentum | 2% ($5โ$31) | 3% ($6โ$40) | Stronger Trend | MPLT |
| Beta / 30D Volatility Risk Regime | 2.24ฮฒ ยท 86% Vol | 1.05ฮฒ ยท 78% Vol | Lower Realized Risk | MPLT |
| Unified Institutional Score Composite Signal | 43.3 / 100 (HOLD) | 50.4 / 100 (HOLD) | Higher Composite | MPLT |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ALMS vs MPLT Buy Guide
ALMS
BREAKDOWN
91d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
8th %ile
IV Regime
Compressed (<25th %ile)
MPLT
BREAKDOWN
144d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
8th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ALMS nor MPLT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.